Revolutionary Ginsenoside Redsenol-1 Plus Gains NCI Accreditation

Redsenol-1 Plus Officially Recognized by the National Cancer Institute

Significant Progress in Botanical Therapeutics

Canada Royal Enoch Phytomedicine Ltd., a pioneer in ginseng and ginsenoside research, is thrilled to announce that its innovative supplement, Redsenol-1 Plus Noble Ginsenosides, has achieved a remarkable milestone. This ginsenoside supplement has been incorporated into the National Cancer Institute's (NCI) Drug Dictionary. This recognition emphasizes Canada Royal Enoch Phytomedicine's dedication to enhancing cancer research while highlighting the potential of Redsenol-1 Plus in oncology and supportive care.

Understanding the NCI Drug Dictionary Listing

The NCI Drug Dictionary serves as an outstanding reference for the definitions and synonyms of drugs and agents used for treating cancer and its related conditions. With its recent definition, Redsenol-1 Plus is now categorized as "an oral and herbal supplement containing sixteen ginsenosides derived from ginseng, including rarer monomer forms like Rg3(R, S), Rh1(S, R), and others..." This unique categorization underlines the diverse range of ginsenosides present in Redsenol-1 Plus.

The Unique Features of Redsenol-1 Plus

What sets Redsenol-1 Plus apart from typical ginseng supplements is its composition. Most ginseng extracts primarily provide a smaller range of large-molecule, less absorbable ginsenosides such as Rg1, Rb1, Rd, Re, and Rc. In contrast, Redsenol-1 Plus has a remarkable mix of sixteen bioactive and easily absorbable rare ginsenosides, with a concentration of 20%. This percentage significantly exceeds those of conventional ginseng supplements, which usually only reach about 4% total ginsenosides.

Technological Advances in Ginsenoside Extraction

Canada Royal Enoch Phytomedicine has developed proprietary technologies for the extraction, processing, transformation, and formulation of rare ginsenosides. These state-of-the-art techniques enable the large-scale production of these beneficial compounds, significantly enhancing the company's position as a global leader in ginsenoside innovation and setting it apart from the competition.

Commitment to Research and Scientific Advancement

“The inclusion of Redsenol-1 Plus in the NCI Drug Dictionary offers researchers a standardized definition of its components,” expressed Dr. Peihua Yu, founder and CEO of Canada Royal Enoch Phytomedicine. “We are committed to advancing the scientific understanding of ginsenoside applications in conditions related to cancer through thorough research.”

Ongoing Clinical Trials with Redsenol-1 Plus

In alignment with the recognition from the NCI, Canada Royal Enoch Phytomedicine is also conducting clinical trials aimed at evaluating Redsenol-1 Plus’s effectiveness in addressing cancer-related fatigue—a common and disruptive symptom faced by patients undergoing treatment. This meticulous, triple-blind, placebo-controlled study is being executed by KGK Science, Inc., a prestigious clinical research organization based in Canada. The success of this trial may not only boost understanding of Redsenol-1 Plus but also shape it as a pivotal solution to alleviate cancer-related fatigue.

About Canada Royal Enoch Phytomedicine Ltd.

Canada Royal Enoch Phytomedicine Ltd. stands at the forefront of biotechnology, specializing in the research, production, and sale of natural, plant-based health solutions. The flagship product line, Redsenol (also known as Redsenol-1, Redsenol-1 Plus, and Redsenol DAG), features high-concentration ginsenoside supplements comprising various rare ginsenosides. Through its unique extraction, transformation, and formulation technologies, Canada Royal Enoch Phytomedicine seeks to unlock the complete potential of ginseng and ginsenosides for health and well-being.

Frequently Asked Questions

What is Redsenol-1 Plus?

Redsenol-1 Plus is an oral herbal supplement featuring sixteen ginsenosides derived from ginseng, noted for its potential benefits in cancer care.

How does Redsenol-1 Plus differ from other ginseng products?

Unlike many ginseng extracts that contain low amounts of active ingredients, Redsenol-1 Plus offers a higher concentration of rare and absorbable ginsenosides, making it significantly more effective.

What are the implications of being listed in the NCI Drug Dictionary?

The NCI Drug Dictionary listing provides researchers with an official definition of Redsenol-1 Plus's components, promoting further studies and applications in cancer research.

Is there ongoing research related to Redsenol-1 Plus?

Yes, Canada Royal Enoch is conducting clinical trials to assess the efficacy of Redsenol-1 Plus in mitigating cancer-related fatigue, aiming to provide substantial evidence for its benefits.

Where can I find more information about Canada Royal Enoch Phytomedicine?

For additional details on Canada Royal Enoch Phytomedicine and its product offerings, you can visit their official website.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.